Dr. Richard Jayaraj
Neuroscientist with over 15 years of international research experience across four countries, specializing in multi-disciplinary pre-clinical and clinical projects spanning in silico, in vitro, and in vivo disease models and human biomarkers. I started my research journey from a humble background, without access to sophisticated labs or resources, yet went on to complete my PhD […]
Jenna Montgomery Harvey, PhD
I am a neuroscience drug discovery scientist with more than 15 years of experience spanning neurophysiology, neurodegenerative disease research, translational biology, and therapeutic development. Throughout my career, I have worked across academia, biotechnology, and pharmaceutical research, advancing programmes from target identification and validation through candidate nomination and early preclinical development. In recent years, I have […]
Gwang Jin (Josephus) Kim
Senior Data Scientist computational biologist PhD Molecular Medicine with long-term experience delivering end-to-end analytics across disease research and Pharma Biotech environments from multi-omics single-cell bulk RNA-seq ChIP/ATAC to applied ML CNNs sequence models and robust reproducible pipelines. Clinical-facing background from a university hospital setting Freiburg Germany worked with patient-derived cohort data under ethics approval informed […]
Carme Uribe, Ph.D.
PhD-level clinical scientist with 10+ years of expertise in CNS neurodegeneration (Parkinson’s disease, Alzheimer’s disease, synucleinopathies, tauopathies, iRBD), seeking a senior medical affairs role. Four core strengths: (1) deep therapeutic expertise across CNS clinical research and biomarker development; (2) hands-on Health Canada-regulated clinical trial execution and regulatory documentation; (3) established credibility with international KOLs and […]
MEHDI SOLEYMANI-GOLOUJEH, Ph.D.
Postdoctoral scientist with 2+ years of post-PhD experience designing and characterizing engineered human pluripotent stem cell lines at the UCSF Diabetes Center. Applies CRISPR/Cas9-based genome engineering, HDR-oriented knock-in/knockout strategies, TALEN-related workflows, and lentiviral effector systems to build hPSC-derived models of inflammation-driven cell death, with multi-lineage differentiation experience relevant to neural and microglial lineage workflows used […]